Invitrogen Corp. (Nasdaq:IVGN - News), a provider of essential life science technologies for disease research and drug discovery, today announced the formation of a Flow Cytometry Scientific Advisory Board to be chaired by Dr. Leonard A. Herzenberg. Dr. Leonore A. Herzenberg will join the board as a member. Together the two Stanford professors will help guide Invitrogen’s efforts to bring its many product lines to bear on immunology, flow cytometry and cell biology.
